人免疫球蛋白联合盐酸氨溴索治疗小儿重症肺炎的临床价值.docVIP

人免疫球蛋白联合盐酸氨溴索治疗小儿重症肺炎的临床价值 　　[摘要] 目的 探讨人免疫球蛋白联合盐酸氨溴索静脉滴注治疗小儿重症肺炎的价值。 方法 选择重症肺炎患儿110例作为研究对象，随机分为观察组给予人免疫球蛋白联合盐酸氨溴索静脉滴注治疗和对照组给予盐酸氨溴索静脉注射治疗，观察疗效相关指标。 结果 观察组患儿治疗后显效率为52.7%，总有效率为94.5%，对照组显效率为34.5%，总有效率为83.6%，观察组患儿治疗效果明显优于对照组（P0.05）。观察组患儿的咳嗽咳痰、肺部??音缓解时间，胸片征象消失时间以及心力衰竭例数均明显少于对照组（P0.05）。 结论 人免疫球蛋白联合盐酸氨溴索滴注治疗能够改善治疗效果，具有积极的临床价值。 　　[关键词] 重症肺炎;人免疫球蛋白;盐酸氨溴索 　　[中图分类号] R722.1 [文献标识码] B [文章编号] 2095-0616（2015）02-58-03 　　Curative effect observation in children of severe pneumonia with hydrochloric acid ammonia bromine joint human immunoglobulin 　　LI Heyun GUO Zhenghong CHEN Wenli 　　Department of A Branch Paediatrics， Zhaotong City First Peoples Hospital， Zhaotong 657000，China 　　[Abstract] Objective To study the curative effect in children of severe pneumonia with Hydrochloric acid ammonia bromine joint Human immunoglobulin. Methods 110 children with severe pneumonia as the research object， were randomLy divided into observation group which was given the Hydrochloric acid ammonia bromine joint Human immunoglobulin，and control group which was only given the Hydrochloric acid ammonia bromine.The effect of related indicators after treatment were observed. Results The efficiency of observation group after treatment in children was 52.7%， the total effective rate was 94.5%，and in the control group was 34.5%，83.6%， Observation group therapy effect was obviously better than the control group（P0.05）. the cough and expectoration， lung rale relief time， the X-ray signs disappear time and heart failure cases of observation group were significantly less than the control group（P0.05）. Conclusion The treatment with hydrochloric acid ammonia bromine joint human immunoglobulin can improve the treatment effect， have positive clinical value. 　　[Key words] Severe pneumonia; Human immunoglobulin; Hydrochloric acid ammonia bromine 　　小儿肺炎是婴幼儿时期最常见的呼吸系统疾病，当发展至重症肺炎的阶段时，病情凶险、特别是低氧血症及心力衰竭，对患儿生命影响最大，如何减少患儿严重的合并症，改善治疗效果，促进病情恢复，减少恶性后遗症是本研究的目的，现报道如下。 　　1 资料与方法 　　1.1 一般资料 　　选择2010年9月～2012年12月间在本院小儿科